banner
grahamabra.bsky.social
@grahamabra.bsky.social
Nephrologist @StanfordNeph, Chair @HDAE_Official, Director Social Media @HemodialysisInt, Defender of the 4 nephrons.
Community house HD continues to be a great example of patient centered care and creative thinking
November 10, 2025 at 2:35 PM
Reposted
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo

@asnkidney.bsky.social | #KidneyWk
November 7, 2025 at 4:36 PM
Reposted
a conservative dialysis strategy in possibly recovering AKI helps people recover faster!

jamanetwork.com/journals/jam...

in @jama.com from #KidneyWk

Like STARRT-AKi et al, at the other end? Small trial - needs replication or this is common sense?
A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury
This trial examines whether a conservative dialysis strategy can improve recovery of kidney function for patients with acute kidney injury who require dialysis.
jamanetwork.com
November 7, 2025 at 6:50 PM
Reposted
large cohort study of
CDK 4/6
BRAF
EGFR
VEGF
and other cancer treatments

#OncoNephrology #NephSky #KidneyWk

jamanetwork.com/journals/jam... from Shuchi Anand et al from @stanfordmedicine.bsky.social
November 6, 2025 at 10:30 PM
Reposted
We are 2 for 2 with positive trials so far. LIBERATE-D shows benefit with a conservative vs conventional dialysis strategy in AKI-D. The difference in mortality is concerning though? Simultaneous pub 👇🏾 #kidneywk

jamanetwork.com/journals/jam...
November 7, 2025 at 5:10 PM
Reposted
Highlights from my talk yesterday on Alport syndrome spectrum of disorders. (since no one posted it, I'll have to do it myself)

Variants in type IV collagen cause a wide spectrum of disease. #KidneyWk 🧵
November 6, 2025 at 6:39 PM
Reposted
ORIGIN phase 3 trial: In an interim analysis of a clinical trial, atacicept, a fusion protein that binds and inhibits two cytokines thought to be central to the pathophysiology of IgA nephropathy, significantly reduced proteinuria. nej.md/3JEq8QL

@asnkidney.bsky.social | #KidneyWk
November 6, 2025 at 2:55 PM
Reposted
Next up in Richard Lafayette about Ataracept in IgAN #KidneyWk
November 6, 2025 at 3:08 PM
Reposted
Up next a panel discussion about the trials #KidneyWk
November 6, 2025 at 3:21 PM
Reposted
The first-ever Home Dialysis Early Program Course is happening today at #KidneyWk2025! 🌟
Thanks to ISPD collaboration with ASN, over 100 attendees can explore the latest trends in home dialysis with great speakers from around the world. Exciting times for kidney care! 🩺#PeritonealDialysis
November 5, 2025 at 11:08 PM
Reposted
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.

med.stanford.edu/nephrology/e...
Hypertension Fellowship
med.stanford.edu
November 5, 2025 at 7:57 AM
Reposted
Moving beyond N of 1 case reports!

The first clinical trial of 🐷 kidneys begins

N = 6, poss or expansion to 50

United Therapeutics (NYU, UAB have used this model)

ca.finance.yahoo.com/news/first-c...
First clinical trial of pig kidney transplants gets underway
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
ca.finance.yahoo.com
November 4, 2025 at 1:15 AM
Reposted
Patient on Automated PD presents with hypotension, abdominal pain , fever for 2 days. Symptoms developed after colonoscopy with polypectomy.
October 31, 2025 at 3:05 PM
Reposted
If you get a clearly pathogenic COL4A5 variant you might be able to stop after genetic testing, but a single COL4A3/4 variant doesn’t tell you what’s going on in the kidney. Still need biopsies. #NephJC
October 29, 2025 at 1:49 AM
Reposted
Big holes:

Precedence of therapies
Options when one therapy runs out (e.g. Nefecon)
Lack of availability + cost of novel therapies
Lack of trials for 2+ concurrent therapies
Lack of apples-to-apples comparisons of therapies

And I love the idea of rolling guidance updates.

#NephJC
October 29, 2025 at 1:57 AM
Reposted
What is the global incidence of IgA nephropathy?

Incidence is varied in different countries depending on urinary screening programs and timing of nephrology referral. There aren’t any validated serum markers and IgAN diagnosis is based exclusively on renal biopsy findings. #NephJC
October 29, 2025 at 1:08 AM
Does China have universal urinary screening in pediatrics?

I have quite a few folks who were diagnosed with IgA Nephropathy early in China before moving to the Bay Area for tech jobs

#NephJC
Diagnosis: 🩺
Occurs in the 3rd- 4th decades of life, often after CKD has already set in.
🚨Highlighting the importance of urinary screening programs; measurement of UACR/UPCR.
Countries like Taiwan,Singapore,Australia had earlier diagnosis because of urinary screening programs. #NephJC
October 29, 2025 at 1:15 AM
Reposted
Brush up on the @kdigo.org IgAN guidelines with this #NephGR from Prof IgA Jon Barratt

youtu.be/OChs5BcTEGE?...

#NephJC in a couple of hours tonight!
Updates to the KDIGO Guidelines for the treatment of IgA nephropathy, with Prof Jonathan Barratt
YouTube video by Ottawa Nephrology
youtu.be
October 28, 2025 at 10:33 PM
Graham Abra

Clinician educator and nephrologist

COI: Recovering Rich Lafayette clinic fellow

#NephJC
October 29, 2025 at 1:07 AM
Reposted
🎨Beautiful visual abstract by Dr Natalia Nombera @roxnonna23.bsky.social #NephJC

www.nephjc.com/news/...
October 29, 2025 at 1:04 AM
Reposted
The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky

✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social

www.nephjc.com/news/igan-kd...
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
www.nephjc.com
October 28, 2025 at 2:06 AM
Reposted
There is an ongoing danish study called APPLE TREE randomizing patients who are being perscribed SGLT2i to either empa, dapa or cana. Maybe we’ll ger the answer here: lundbeckfonden.com/en/the-apple...
The APPLE TREE study
Daniel Christensen, Department of Cardiology, Herlev and Gentofte Hospital, has been awarded an Early-career clinician scientist research grant worth DKK 916.199.
lundbeckfonden.com
October 21, 2025 at 6:34 PM
Reposted
U-Sed Case

👨‍⚕️ 46M with uveitis + acute kidney injury (Cr 0.7 → 4.4 mg/dL)

💬 Symptoms: cough, dyspnea, vomiting, 10-kg weight loss

🧪 Urinalysis: pathologic
🩻 Kidneys: normal size

💭 Could this uveitis + AKI pattern suggest a systemic autoimmune process?
October 23, 2025 at 2:12 AM